Letter/Comment
The latest advocacy letters and comments from the 黑料正能量 Association.
The AHA asks the Department of Health and Human Services (HHS) to take additional steps to increase flexibilities for providers responding to the COVID-19 pandemic.
Nineteen organizations representing physicians and hospitals, including the AHA, urge congressional leaders to support legislation to freeze the thresholds for clinicians to qualify for advanced alternative payment model incentive payments for the 2021 and 2022 performance years.
Confronting the challenges of the pandemic is imperative to saving American lives. Real-time data and information on the supply of therapeutics, testing supplies, personal protective equipment, ventilators, hospital bed capacity and workforce availability to plan for further deployment of the鈥
The Department of Health and Human Services should fully reinstate its June COVID-19 Provider Relief Fund reporting requirements, AHA said again today in a letter to the agency.
The AHA on Friday sent a letter to the Health Resources and Services Administration鈥檚 Office of Pharmacy Affairs urging the agency to order drug manufacturers and their vendor Kalderos to immediately halt their conversion of the 340B program to a back-end rebate program.
AHA comments on the Centers for Medicare & Medicaid Services鈥 proposed revision to the definition of 鈥渞easonable and necessary鈥 for purposes of Medicare coverage determinations. View entire comment letter under Key Resources.
AHA letter urging the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with 鈥渇requently changing and confusing鈥 COVID-19 data collection efforts.
In a letter to Senator Lamar Alexander and Representative Greg Walden, AHA expresses strong support for the 340B Drug Pricing Program.
Please contact your representatives today and ask them to sign onto a bipartisan 鈥淒ear Colleague鈥 letter to Department of Health and Human Services Secretary Alex Azar expressing concern about recent efforts by Kalderos to transition the 340B Drug Pricing Program from one of up-front discounts to鈥
As the House Energy and Commerce Committee investigates health insurance company performance during the COVID-19 pandemic, AHA urges the committee to ensure insurance premiums support access to care.